Aggressive multiple myeloma presenting as mesenteric panniculitis

J Goh1, B Otridge, H Brady

  • 1Department of Gastroenterology, Mater Misericordiae Hospital and University College, Dublin, Ireland.

Insights

Mesenteric panniculitis, a rare bowel condition, can sometimes mask aggressive hematological malignancies. This case highlights a patient initially diagnosed with mesenteric panniculitis who later developed IgA kappa chain myeloma.

Area of Science:

  • Gastroenterology and Oncology
  • Pathology and Immunology

Background:

  • Mesenteric panniculitis is a rare idiopathic inflammatory condition of the bowel mesentery.
  • It typically presents with abdominal pain or fever and has a generally benign prognosis.

Observation:

  • A 43-year-old male presented with malaise, weight loss, microcytic anemia, and elevated erythrocyte sedimentation rate.
  • Radiographic and histological findings confirmed mesenteric panniculitis, which initially responded well to high-dose oral prednisolone.

Findings:

  • The patient relapsed within six months with anemia, renal failure, and hypercalcemia.
  • A diagnosis of IgA kappa chain myeloma was established.
  • This case represents the first documented instance of a hematological malignancy initially presenting as mesenteric panniculitis with a fatal outcome.

Implications:

  • Mesenteric panniculitis may be an initial manifestation of underlying hematological malignancies.
  • Further investigation is warranted for patients with unexplained or recurrent mesenteric panniculitis.
  • This case underscores the importance of considering systemic diseases in the differential diagnosis of mesenteric panniculitis.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...